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Abstract: Our objective in this study was to review the experience of a one-stop 
multidisciplinary bone metastases clinic (BMC) that offers a coordinated multidisciplinary 
approach to the care of cancer patients with bone metastases in a tertiary cancer centre. Patients 
with symptomatic bone metastases were referred to BMC and assessed by a team of specialists 
in various disciplines – interventional radiology, orthopedic surgery, palliative medicine, and 
radiation oncology. At initial consultation, patient demographics, reasons for referral, and case 
disposition were recorded. From January 1999 to February 2005, a total of 272 patients with 
bone metastases were referred to the BMC. The median age was 65 years (range 28–95) and 
median KPS score at consultation was 60 (range 30–90). The majority of patients came from 
home (74%), while others came from a nursing home or the hospital (9%). Almost a third (28%) 
of patients had 2 or more reasons of referral, yielding a total of 354 reasons. The most common 
reason for referral was bone pain (42%), bone metastases (21%), high risk for pathological 
fracture (12%), and pathological fracture (10%). Of the 272 patients who received consultation, 
40% received palliative radiotherapy, 19% received interventional surgery, 7% were referred to 
other support services such as palliative care, physiotherapy, and 7% had further investigation 
or imaging. A multidisciplinary clinic is useful for co-coordinating the management of bone 
metastatic disease in symptomatic patients.
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Introduction
In 2006, approximately 153,100 new cases of cancer and 70,400 deaths from cancer 
will occur in Canada (CCS/NCIC 2006). Bone metastases are a frequent complication 
of cancer, and half of the individuals who died of cancer have bone metastates (Rubens 
1998). Breast and prostate carcinomas are the most common to develop metastases to 
bone, with an incidence of 75% and 68%, respectively (Perez et al 1990). In addition, 
lung, thyroid, and renal carcinoma metastasize to bone in approximately 40% of cases 
(Rubens 1998). With advances in effective systemic treatment and supportive care, 
the duration of survival of patients with bone metastases has improved substantially. 
Certain subsets of patients with bone metastases (eg, breast and prostate cancer with 
predominately bone or bone-only metastases) have life expectancies that range from 
two to ﬁ  ve years. The ﬁ  ve-year survival rate of breast cancer patients with either bone 
or bone-only metastases can be as high as 45%, and those with bone-only metastases 
have a median survival of 52 months (Perez et al 1990; Yamashi et al 1991, 1992). Thus, 
successful management of bone metastases during these years is essential for reducing 
skeletal complications and for maximizing patient quality of life. The following reasons 
demonstrate an urgent need to reassess the management strategies in patients with bone 
metastases (Body 1992; Bilezikian 1992; Orr et al 1993; Chow et al 1999):Journal of Pain Research 2008:1 44
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1.  Pain arising from bone metastases is the most common 
symptom requiring radiotherapy treatment in cancer 
patients;
2.  The symptoms of bone metastases are often severe 
and develop earlier in the clinical course of patients 
with cancer than symptoms due to either liver or lung 
metastases;
3.  Complications of skeletal metastases are common and can 
seriously impair patient quality of life and function. Pain 
and impaired mobility occur in 65%–75% of patients with 
bone metastases; fractures of weight-bearing long bones 
occur in 10%–20%; hypercalcemia occurs in 10%–15%; 
and spinal cord or nerve root compression occurs in 5%;
4.  Increasing incidence of bone metastases and longer 
survival duration of patients with bone metastases has 
been observed and;
5.  The care of this group of patients has been poorly 
integrated and coordinated.
Fifty to 75% of patients with bone metastases suffer 
from severe pain (Cleeland et al 1996). As reﬂ  ected in 
a consensus statement from a National Cancer Institute 
workshop, the under-treatment of cancer pain is a serious 
and often neglected public health problem (Jacox et al 1994). 
Treatment for symptomatic bone metastases often involves 
multiple care providers including medical and radiation 
oncologists, pain specialists, surgeons, and other health care 
professionals. Clinical trials in various disciplines addressing 
the optimal management of bone metastases are under 
way and treatment options for bone metastases have been 
expanding as reﬂ  ected in the latest clinical trials testing the 
newer generations of bisphosphonates (Weinfurt et al 2006) 
and increased use of orthopedic surgery.
Radiotherapy and orthopedic stabilization are effective 
palliative measures for bone metastases. Singer commented 
that “bone pain from mechanical effects often necessitates 
long term treatment with strong analgesics” (Singer 1997). In 
response, Krikler (1997) stated that the most effective solution 
for mechanical pain is surgery. Galasko (1997) reported that 
surgical stabilization of such lesions often gives the patient 
total pain relief and may obviate the need for analgesics. 
Although such therapies are effective in alleviating pain, 
specialists who deliver the treatments often work indepen-
dently, leading to the lack of a coordinated treatment. This 
is evident in the review by O’Donoghue and colleagues 
(1997) of 269 women with breast cancer who had developed 
bone metastases. Eighty- two episodes of structurally 
signiﬁ  cant bone destruction in 47 women were identiﬁ  ed. The 
researchers concluded that clinical review by an orthopaedic 
surgeon would have been appropriate in 89% of the episodes, 
but such a review was sought in only 46%. Surgery would 
have been feasible for 65% of the episodes, but was carried 
out in only 31%. Bracing would have been appropriate in 
40% of episodes, but was provided in only 18%.
To date, only one published report exists that describes 
an integrated clinic model for the multidisciplinary 
management of bone metastases. The clinic was developed 
at the University of Texas M.D. Anderson Cancer Centre 
to provide an effective and comprehensive management of 
bony metastases (McQuay et al 1999). In total, presenting 
symptoms and the extent of disease of 108 patients were 
retrospectively evaluated. Presenting symptoms were 
evaluated with the Wisconsin Brief Pain Inventory. Patients 
were assessed by staff physicians from diagnostic radiology, 
nuclear medicine, pain and symptom management, physical 
medicine and rehabilitation, orthopedic surgery, medical 
oncology and radiotherapy. The assessment included a review 
of past therapies, evaluation of current treatment options 
and consideration of underlying medical conditions. Janjan 
and colleagues (1998) suggested that the use of multidis-
ciplinary coordination of care can help to overcome many 
practical difﬁ  culties and address speciﬁ  c problems in the 
management of metastatic disease in symptomatic patients.
The Division of Orthopedics at Sunnybrook Health 
Sciences Centre and the Rapid Response Radiotherapy 
Program at Toronto Sunnybrook Regional Cancer Centre 
initiated a first-of-its-kind clinic, the Bone Metastases 
Clinic, at the Toronto-Sunnybrook Regional Cancer Centre 
in January 1999. The clinic aims to provide a coordinated 
multidisciplinary approach to the care of cancer patients 
with bone metastases. This multidisciplinary service will 
also save the time and effort that a patient would otherwise 
expend during separate, sequential visits to various specialists 
for consultation.
This paper is to report our experience at the Bone 
Metastases Clinic since its inception in 1999.
Methods
The BMC is managed by a team of specialists in various 
disciplines: interventional radiology, nursing, orthopedic 
surgery, pain and palliative medicine, radiation oncology, 
and radiation therapy. The clinic sees patients every second 
and fourth Friday of each month.
A prospective database has been set up for patients 
referred for joint consultation at BMC since January 1999. 
The referral required a pathological diagnosis of cancer 
and documentation of bone metastatic disease either by Journal of Pain Research 2008:1 45
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pathological conﬁ  rmation, clinical examination or imaging 
studies. Patients were enrolled into the database if they 
were able to speak English, give verbal consent and respond 
to questions that assessed their symptoms. Patients were 
excluded from the database if they were confused, refused, 
or were unable to complete the symptom assessment.
During the initial consultation, patient demographics, 
cancer history, disease status and symptom proﬁ  les were 
collected. Patients were asked to rate their symptom 
distress using the Edmonton Symptom Assessment Scale 
(ESAS) with an 11 point categorical scale (0–10, 0 = lack of 
symptom, 10 = worst possible symptom). The scale evaluates 
nine symptoms (pain, fatigue, nausea, depression, anxiety, 
drowsiness, appetite, sense of well-being, and shortness of 
breath). Analgesic consumption, site(s) of bone metastases 
and the risk of fractures at the ﬁ  rst visit were assessed and 
recorded. The functional status of the patient was scored 
as follows: normal with pain free use of the extremity 
and spine; normal use with pain; signiﬁ  cant limited use 
(eg, use of prosthesis, walker, cane, crutches, and sling); 
and nonfunctional extremity/ spine (wheelchair bound, 
bedridden).
Patients were assessed by an orthopaedic surgeon, a 
radiation oncologist and a pain specialist at the consultation. 
The team then made a joint recommendation based on 
their assessments. Nursing and radiation therapy support 
was also provided. If the patient was a candidate for 
percutaneous vertebroplasty, an interventional radiologist 
was consulted.
Results
Patient characteristics and baseline 
symptom distress
From January 1999 to February 2005, a total of 272 patients 
with bone metastases were referred to the BMC. One hundred 
and seven patients were female (54%) and 125 were male 
(46%). Their median age was 65 years and the three most 
common primary sites were breast (31%), lung (21%) and 
prostate (11%). The median KPS score at consultation was 
60 (range 30–90). The majority of patients (74%) arrived 
from their home, and only 9% arrived from a hospital or a 
hospice facility. About 10% of the patients had signiﬁ  cant 
weight loss, which was deﬁ  ned as  10% over the last 
6 months (Table 1). A total of 354 reasons for referral were 
recorded, where almost a third (28%) of patients had 2 or 
more reasons of referral. The top three reasons for referral 
were bone pain (42%), bone metastases (21%) and high risk 
for pathological fracture (12%). Patients identiﬁ  ed the spine 
(41%), pelvis and hips (26%), lower limbs (17%), and upper 
limbs (13%) as the most painful bony sites (Table 2).
Table 3 summarizes the ESAS scores at initial consultation. 
Fatigue and the sense of wellbeing were the two most severe 
Table 1 Patient characteristics (n = 272)
Sex
 Male 147  (54%)
 Female 125  (46%)
Age (years)
  Median (range) 65 (28–95)
Primary cancer site
 Breast 84  (31%)
 Lung 56  (21%)
 Prostate 30  (11%)
  Multiple Myeloma 21 (8%)
 Kidney 20  (7%)
 Unknown 21  (7%)
 Gastrointestinal 16  (6%)
 Others 24  (9%)
Weight loss  10% over the last 
6 months
22 (10%)
Karnofsky performance score
  Median (range) 60 (30–90)
Painful bony sites
 Spine 111  (41%)
 Pelvis/Hips 70  (26%)
  Lower limbs 45 (17%)
  Upper limbs 35 (13%)
 Trunk 8  (3%)
 Others 3  (1%)
Patient arrived from
 Home 200  (74%)
 Hospital/Hospice 24  (9%)
 Other 9  (3%)
 Unknown 39  (14%)
Table 2 Reason(s) for referral*
Bone pain 147 (42%)
Bone metastases 76 (21%)
High risk for pathological fracture 41 (12%)
Pathological fracture 34 (10%)
Spinal cord compression 20 (5%)
Other pain 16 (5%)
Others 20 (6%)
Note: *354 reasons in total for n = 272.Journal of Pain Research 2008:1 46
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symptoms that patients experienced (median of 4 and 3.5, 
respectively). Pain, depression and anxiety were also 
bothersome, with a median score of 3.
Orthopaedic assessment
At consultation, the staff orthopaedic surgeon’s assessment 
was recorded. The functional status of the affected extrem-
ity/spine, the presence or risk of fractures and the severity 
of the risk was recorded. The report was completed only 
about 50% of the time (n = 137). The records show that 
35% of the patients reported signiﬁ  cant limited use of their 
affected extremity or spine (as evident in the use of prosthe-
sis, walker, cane, crutches and sling), 25% reported normal 
use with pain, 15% reported complete nonfunctional use 
(wheelchair-bound or bedridden) and 14% had normal and 
pain free use (Table 4).
When assessed for the presence or risk of fractures, it was 
found that 47% of patients were at a high risk of fractures, 
34% were at low risk and 12% presented with a fracture 
at consultation (Table 5). Of the 65 patients in high risk, 
34 (52%) of them had a high risk of fractures at the extremi-
ties, where 22 of them (65%) presented with a lytic lesion 
that was  2.5 cm in size at their extremities. Thirty patients 
(46%) were classiﬁ  ed to have a high risk of fracture at the 
spine because of mechanical instability (16/30), spinal cord 
compression (12/30), cauda equina syndrome or more than 
two nerve root deﬁ  cits (2/30).
Case dispositions and recommendations
After thorough examination and evaluation of a patient’s 
symptoms, the BMC team discussed to suggest the best course 
of action. Of the 272 patients who received consultation, 40% 
received palliative radiotherapy, 19% received interventional 
surgery, 7% were referred to other support services such as 
physiotherapy, and 7% had further investigation or imaging 
completed (Table 6).
Discussions
Optimal management of structurally signiﬁ  cant bony metas-
tases often requires an overall effort to restore and maintain 
function, as well as relieve cancer-related pain. Pain is the 
most frequent symptom of bone metastases. It develops 
slowly and becomes progressively more severe. In the early 
stages, pain can mostly be controlled with acetaminophen, 
anti-inﬂ  ammatory agents and opiates. Despite being on a 
stable opioid treatment regimen, incident pain (a transitory 
ﬂ  are of pain upon movement) is a common compliant among 
patients with bone metastases (Portenoy and Hagen 1990). 
This type of pain restricts patients from normal activities and 
interferes with their ability to function.
When pain becomes progressively worst and patients 
fail to respond to drug therapy, alternative therapies must be 
considered. For the majority of patients with bone metasta-
ses, radiotherapy provides excellent palliation for localized 
bone pain. In 66% of patients, radiotherapy provided partial 
pain relief after a median time of 3 to 4 weeks (McQuay 
et al 1999). However, patients may also experience epi-
sodes of an intensiﬁ  cation of pain (pain ﬂ  are) shortly after 
radiotherapy. About 14% of the patients receiving single dose 
Table 3 Symptom distress according to the Edmonton symptom assessment scale
Symptom N Mean Standard deviation Median Range
Pain 100 3.88 3.31 3.0 0–10
Fatigue 90 4.50 2.72 4.0 0–10
Nausea 91 1.09 1.88 0.0 0–9
Depression 83 2.75 2.57 3.0 0–10
Anxiety 87 3.33 2.77 3.0 0–10
Drowsiness 88 2.50 2.60 2.0 0–10
Appetite 90 3.28 3.26 2.5 0–10
Sense of well-being 86 3.95 2.59 3.5 0–10
Shortness of breath 90 1.86 2.36 1.0 0–9
Notes: 0, lack of symptom; 10, worst possible symptom.
Table 4 Functional status of extremity/spine (n = 137)
Status
Signiﬁ  cant limited use 48 (35%)
Normal use with pain 34 (25%)
Nonfunctional 20 (15%)
Normal, pain-free use 19 (14%)
Unknown 16 (12%)Journal of Pain Research 2008:1 47
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of radiation experience pain ﬂ  are on both day one and day 
two (Chow et al 2005). Thus, modiﬁ  cations to the patient’s 
analgesic regimen are necessary to control symptoms both 
during and after radiotherapy. However, the pain relieving 
effect of radiotherapy is not permanent. A median time to 
pain progression is 5 to 6 months following radiotherapy 
(Steenladn et al 1999), and about 40% of patients experience 
an increase in pain after one year (BPT 1999). Retreatment 
is often also required when the effects of radiotherapy 
wears off. In a large RCT (Steenland et al 1999), 16% of all 
patients required re-treatment. The rate of retreatment was 
signiﬁ  cantly more pronounced in patients who previously 
received a single fraction than those who received multiple 
fractions regimens (25% vs 7%). Other than palliating 
pain, radiotherapy can also be used to prevent a pathologic 
fracture and treat neurological complications from spinal cord 
compression (Blum et al 2003). However, when radiotherapy 
is inadequate to palliate pain or manage such complications, 
surgery may be indicated.
“Orthopedic surgery is often prescribed to palliate bone 
pain and restore function. Patients can benefit from 
procedures such as intramedullary nailing, or prophylactic 
internal ﬁ  xation when the risk of pathological fracture is 
signiﬁ  cant. To prevent further tumor growth and bone 
loss, radiotherapy should follow surgery. Newer minimally 
invasive procedures such as percutaneous vertebroplasty 
and kyphoplasty are also highly effective in treating painful 
vertebral compressive fractures and preventing future 
vertebral collapse.”
—(Forney et al 2003)
The complicated disease trajectory in patients with bone 
metastases necessitates a multidisciplinary effort between 
various specialties to provide symptom relief, maintain or 
restore function, and improve patients’ quality of life. Effective 
and comprehensive management approaches are imperative to 
ensure patients receive effective symptom and pain control and 
are assessed for: i) the risk of other complications that require 
emergent interventions and ii) the need for other therapies 
and support service. The Toronto Sunnybrook Regional 
Cancer Centre Bone Metastases Clinic demonstrates that the 
integration of services allows for more streamlined care and 
eliminates the inconvenience of separate visits to various spe-
cialists for consultation. With one visit, the patient beneﬁ  ts from 
a multidisciplinary evaluation that assesses the appropriate 
intervention to palliate the presenting symptoms (Figure 1). 
Patients can also beneﬁ  t from an additional resource: a 40-page 
educational binder titled “Helping You to Help Yourself   ” 
Table 5 Presence of bone metastasis fractures/risk of fracture 
(n = 137)
Presence of fracture
 Pathological 14  (10%)
 Wedge 3  (2%)
Total presence of fracture: 17 (12%)
  Low risk 46 (34%)
 High  risk
Extremities: 50%–74% cortex involved 5 (4%)
   75% cortex involved 6 (4%)
  Lytic lesion 2.5 to 5 cm in size 11 (8%)
 Lytic  lesion    5 cm in size 5 (4%)
  Subtrochanteric region of femur 7 (5%)
Spine: Mechanical instability 16 (12%)
   Cauda equine syndrome OR   2 
nerve root deﬁ  cits
2 (1%)
  Spinal cord compression 12 (9%)
  No reason: 1 (1%)
Total high risk 65 (47%)
None 9 (7%)
Table 6 Case disposition and treatment recommendations (n = 280*)
Radiotherapy 108 (40%)
Surgery 53 (19%)
Other support services 19 (7%)
Further investigation and imaging 18 (7%)
No action 69 (25%)
Others 13 (4%)
Notes: *4 patients received two treatment recommendations.
Orthopedics
Pharmacy
Pain & palliative care
Nursing
Radiation oncology 
Referrals
Recommendation
Figure 1 Bone metastases clinic.Journal of Pain Research 2008:1 48
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Pope 2004). The resource book was developed speciﬁ  cally 
for patients with bone metastases by the BMC team and the 
nurse coordinator of the clinic. Contents include treatment 
information, coping strategies, tips on effective management 
of pain and fatigue, community resources, bone metastases 
diagnosis information and relevant case studies (Pope 2004).
One limitation of the study is the incomplete data on 
symptom distress measured by the ESAS and recorded 
on orthopaedic assessments. Modifications to patients’ 
analgesic regimen should also be carefully recorded. Future 
studies should investigate improved methods of collecting 
the information, examining quality of life measures, patient 
satisfaction and the cost-effectiveness of the clinic.
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